0R9T Stock Overview
Equasens Société anonyme provides healthcare IT solutions in Europe.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 0R9T from our risk checks.
Equasens Société anonyme Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €61.29 |
| 52 Week High | €85.60 |
| 52 Week Low | €46.50 |
| Beta | 0.94 |
| 1 Month Change | 19.25% |
| 3 Month Change | 7.26% |
| 1 Year Change | -15.34% |
| 3 Year Change | -39.43% |
| 5 Year Change | 8.87% |
| Change since IPO | 234.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0R9T | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | 3.2% | -2.3% | 1.2% |
| 1Y | -15.3% | 66.1% | -0.3% |
Return vs Industry: 0R9T underperformed the UK Healthcare Services industry which returned 66.1% over the past year.
Return vs Market: 0R9T underperformed the UK Market which returned -0.3% over the past year.
Price Volatility
| 0R9T volatility | |
|---|---|
| 0R9T Average Weekly Movement | 5.2% |
| Healthcare Services Industry Average Movement | 7.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0R9T has not had significant price volatility in the past 3 months.
Volatility Over Time: 0R9T's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,200 | Denis Supplisson | equasens.com |
Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id.
Equasens Société anonyme Fundamentals Summary
| 0R9T fundamental statistics | |
|---|---|
| Market cap | €917.03m |
| Earnings (TTM) | €48.50m |
| Revenue (TTM) | €223.12m |
18.9x
P/E Ratio4.1x
P/S RatioIs 0R9T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0R9T income statement (TTM) | |
|---|---|
| Revenue | €223.12m |
| Cost of Revenue | €150.32m |
| Gross Profit | €72.81m |
| Other Expenses | €24.31m |
| Earnings | €48.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Sep 27, 2024
| Earnings per share (EPS) | 3.23 |
| Gross Margin | 32.63% |
| Net Profit Margin | 21.74% |
| Debt/Equity Ratio | 28.9% |
How did 0R9T perform over the long term?
See historical performance and comparison